⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL994101 | 0.79 | — | — | |
| SCHEMBL9494293 | 0.77 | — | — | |
| SCHEMBL9494298 | 0.72 | — | — | |
| SCHEMBL6513766 | 0.68 | — | — | |
| SCHEMBL4866615 | 0.65 | — | — | |
| SCHEMBL3902544 | 0.65 | TSHR (0.31) | — | |
| SCHEMBL3951484 | 0.64 | — | — | |
| SCHEMBL10980388 | 0.59 | — | — | |
| SCHEMBL19132144 | 0.59 | TSHR (0.31) | — | |
| SCHEMBL2076631 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025053766-A2 | DINUCLEOTIDE MONOPHOSPHATE DERIVATIVE, THE NUCLEIC ACID DERIVATIVE CONTAINING IT, AND THE METHOD OF OBTAINING IT | SIEĆ BADAWCZA ŁUKASIEWICZ PORT POLSKI OŚRODEK ROZWOJU TECHNOLOGII (PL) | 2025-03-13 | — | — | WO | disclosed |
| US-20240182512-A1 | N-(2-AMINOETHYL)MORPHOLINE-BASED RNA ANALOGS, METHOD FOR THE PREPARATION AND USE THEREOF | UNIWERSYTET WARSZAWSKI (PL) | 2024-06-06 | — | — | US | disclosed |
| EP-4305045-A1 | N-(2-AMINOETHYL)MORPHOLINE-BASED RNA ANALOGS, METHOD FOR THE PREPARATION AND USE THEREOF | Uniwersytet Warszawski (PL) | 2024-01-17 | — | — | EP | disclosed |
| US-20230295215-A1 | NOVEL MRNA 5'-END CAP ANALOGS MODIFIED WITHIN PHOSPHATE RESIDUES, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE | UNIWERSYTET WARSZAWSKI (PL) | 2023-09-21 | — | — | US | disclosed |
| US-20230250127-A1 | MODIFIED mRNA 5'-CAP ANALOGS | Nanjing GeneLeap Biotechnology Co., Ltd. (CN) | 2023-08-10 | — | — | US | disclosed |
| EP-4103578-A1 | NOVEL MRNA 5'-END CAP ANALOGS MODIFIED WITHIN PHOSPHATE RESIDUES, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE | Uniwersytet Warszawski (PL) | 2022-12-21 | — | — | EP | disclosed |
| WO-2021162566-A1 | NOVEL MRNA 5'-END CAP ANALOGS MODIFIED WITHIN PHOSPHATE RESIDUES, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE | UNIWERSYTET WARSZAWSKI (PL) | 2021-08-19 | — | — | WO | disclosed |
| US-10131908-B2 | 5′ phosphate mimics | ALNYLAM PHARMACEUTICALS, INC. (US) | 2018-11-20 | — | — | US | disclosed |
| US-20150080457-A1 | 5' PHOSPHATE MIMICS | BANK OF AMERICA, N.A. | 2015-03-19 | — | — | US | disclosed |
| US-8927513-B2 | 5′ phosphate mimics | ALNYLAM PHARMACEUTICALS, INC. (US) | 2015-01-06 | — | — | US | disclosed |
| US-20120157511-A1 | 5' PHOSPHATE MIMICS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2012-06-21 | — | — | US | disclosed |
| WO-2011005860-A2 | 5' PHOSPHATE MIMICS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2011-01-13 | — | — | WO | disclosed |